Search and analyze individual stocks with comprehensive metrics

Lupin Limited

LUPINPharmaceuticals & Biotechnology

Fundamental Score

...

Lupin Limited Share Price & Market Analysis

Current Market Price (CMP)
1990.90
No change data available
Market Cap
90.99K (Cr)
Industry
Pharmaceuticals & Biotechnology

Profitability Metrics

Excellent

Return on Equity

20.62%
Excellent

Return on Capital Employed

21.30%
Excellent

Operating Profit Margin (5Y)

14.94%
Average

Dividend Yield

0.60%

Valuation Metrics

Good

Price to Earnings

24.60x

Market Capitalization

90.99K (Cr)

Industry P/E

33.97x

Growth Metrics

Excellent

YoY Quarterly Profit Growth

52.13%
Poor

YoY Quarterly Sales Growth

11.93%
Poor

Sales Growth (5Y)

8.11%
Excellent

EPS Growth (5Y)

54.69%
Excellent

Profit Growth (5Y)

54.88%

Financial Health

Excellent

Debt to Equity

0.32x
Excellent

Interest Coverage

14.93x
Excellent

Free Cash Flow (5Y)

5.13K (Cr)

Ownership Structure

Average

Promoter Holding

46.90%
Excellent

FII Holding

21.25%
Excellent

DII Holding

25.55%
Excellent

Pledged Percentage

0.00%
Market-cap Classification
Large-cap
Established & liquid; typically steadier returns.
46.90%
Promoter Holding
90.99K (Cr)
Market Cap

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Market Data Analysis & Educational Insights

Educational evaluation of LUPIN across key market metrics for learning purposes.

Positive Indicators

10 factors identified

Strong Return on Equity (20.62%)

Observation: Efficient use of shareholders' capital generating superior returns.

Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.

Excellent ROCE Performance (21.30%)

Observation: Superior returns on capital employed across business operations.

Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance. This indicates quality business fundamentals.

Attractive Valuation (P/E: 24.60 vs Industry: 33.97)

Observation: Trading at discount to industry peers.

Analysis: P/E below industry average may present value opportunity if fundamentals support the business case.

Robust Profit Growth (52.13%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture. This suggests positive business trajectory.

Excellent EPS Growth (54.69% CAGR)

Observation: Outstanding 5-year earnings per share compound growth.

Analysis: EPS CAGR >15% indicates strong wealth creation potential and effective capital allocation over extended periods.

Strong Profit Growth Track Record (54.88% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model and effective operational leverage over time.

Strong Interest Coverage (14.93x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk and strong debt servicing capability.

Strong Cash Generation (₹5134.41 Cr over 5Y)

Observation: Healthy free cash flow generation supports growth and returns.

Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.

Strong Institutional Confidence (FII+DII: 46.80%)

Observation: Significant professional investor participation indicates quality recognition.

Analysis: High institutional holding often signals thorough due diligence and quality business fundamentals.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral, reducing forced-selling risk.

Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.

Risk Factors

0 factors identified

No significant concerns identified in current analysis.

📊 Educational Market Overview

Disclaimer: The ratings and scores are generated algorithmically from publicly available market data and are provided for educational and informational purposes only. They do not constitute investment advice, recommendation, or solicitation to buy/sell any securities.

Loading Peer Comparison

Finding companies in the Pharmaceuticals sector...

Financial Statements

Comprehensive financial data for Lupin Limited

About LUPIN

Company Details

Symbol:LUPIN
Industry:Pharmaceuticals & Biotechnology
Sector:Pharmaceuticals

Market Information

Market Cap:90.99K (Cr)
P/E Ratio:24.60
Beta:N/A

Performance

52W High:N/A
52W Low:N/A
Dividend Yield:0.60%

LUPIN Stock Details & Analysis

Key Financial Metrics

Return on Equity (ROE)20.62%
Return on Capital Employed21.30%
Operating Profit Margin (5Y)14.94%
Debt to Equity Ratio0.32
Interest Coverage Ratio14.93

Growth & Valuation

Sales Growth (5Y)8.11%
Profit Growth (5Y)54.88%
EPS Growth (5Y)54.69%
YoY Quarterly Profit Growth52.13%
YoY Quarterly Sales Growth11.93%

Frequently Asked Questions

What is the current price of LUPIN?

LUPIN is currently trading at ₹1990.90 with a gain of 0.00% today. The current market price (CMP) represents the last traded price of LUPIN shares on the stock exchange. This price fluctuates throughout trading hours based on supply and demand. You can track real-time price movements, percentage changes, and trading volume in the header section.

What is the P/E ratio of LUPIN and what does it mean?

LUPIN has a P/E ratio of 24.60x compared to the industry average of 33.97x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹25 for every ₹1 of annual earnings. This is lower than the industry average, which might indicate undervaluation or slower growth expectations.

How is LUPIN performing according to Bull Run's analysis?

LUPIN has a Bull Run fundamental score of 69.8/100, which indicates moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters including profitability (ROE: 20.62%), growth metrics, valuation ratios, and financial health indicators. The score updates quarterly with new financial data and helps you quickly assess overall investment quality.

What sector and industry does LUPIN belong to?

LUPIN operates in the Pharmaceuticals & Biotechnology industry. This sector classification helps understand the broader economic trends, regulatory framework, and competitive landscape affecting Lupin Limited. Companies in this industry typically face similar market dynamics, cyclical patterns, and macroeconomic factors. Understanding the industry context is crucial for peer comparison and assessing how sector-specific trends might impact the stock's performance.

What is Return on Equity (ROE) and why is it important for LUPIN?

LUPIN has an ROE of 20.62%, which indicates excellent management efficiency and profitable operations. Return on Equity measures how efficiently Lupin Limited generates profits from shareholders' equity. An ROE of 21% means the company generates ₹21 profit for every ₹100 of shareholders' equity. This metric is crucial for assessing management's ability to create value for shareholders.

How is LUPIN's debt-to-equity ratio and what does it indicate?

LUPIN has a debt-to-equity ratio of 0.32, which indicates moderate leverage that should be monitored. This means the company has ₹32 of debt for every ₹100 of equity. This conservative approach provides financial stability but may limit growth potential.

What is LUPIN's dividend yield and is it a good dividend stock?

LUPIN offers a dividend yield of 0.60%, which means you receive ₹0.60 annual dividend for every ₹100 invested. The focus appears to be more on growth rather than dividend income. Dividend yield is calculated as annual dividend per share ÷ current share price × 100. Evaluate dividend consistency over 5+ years and free cash flow coverage for sustainability.

How has LUPIN grown over the past 5 years?

LUPIN has achieved 5-year growth rates of: Sales Growth 8.11%, Profit Growth 54.88%, and EPS Growth 54.69%. These growth metrics show the company's ability to expand its business and improve profitability over time. Sales growth indicates market expansion, profit growth shows operational efficiency, and EPS growth directly impacts share price appreciation potential.

What is the promoter holding in LUPIN and why does it matter?

Promoters hold 46.90% of LUPIN shares, with 0.00% of promoter shares pledged. This promoter holding level suggests balanced ownership between management and public shareholders. Low pledging indicates financial stability of promoters. Recent change in promoter holding: -0.02%.

How does LUPIN compare with its industry peers?

LUPIN trades at P/E 24.60x vs industry average 33.97x, with ROE of 20.62% and ROCE of 21.30%. The stock appears undervalued relative to peers based on P/E ratio. Peer comparison helps identify whether LUPIN is outperforming its competitive set in profitability, growth, and valuation metrics.

What is LUPIN's market capitalization and what category does it fall into?

LUPIN has a market capitalization of ₹90994 crores, making it a Large-cap stock. Large-cap stocks offer stability and liquidity but typically slower growth. Market cap is calculated as current share price × total outstanding shares, representing the company's total market value.

What are the key financial ratios to consider for LUPIN?

Key ratios for LUPIN: ROE 20.62% (Excellent), ROCE 21.30%, P/E 24.60x, Debt-to-Equity 0.32, Interest Coverage 14.93x. These ratios help assess profitability (ROE, ROCE), valuation (P/E), financial health (D/E, Interest Coverage), and overall investment quality. Compare these with industry medians and historical trends for meaningful analysis.

How volatile is LUPIN stock and what is its beta?

LUPIN has a beta of N/A, which means it is less volatile than the market and offers defensive characteristics. Beta measures price volatility relative to the Nifty 50. Lower beta stocks provide stability during uncertain market conditions. Consider beta alongside your risk tolerance and portfolio diversification strategy.

What is the 52-week high and low for LUPIN?

LUPIN has a 52-week high of ₹N/A and low of ₹N/A. Currently trading at ₹1990.90, the stock is within its annual trading range. Trading near highs indicates strong momentum but limited upside potential.

What are the key risks associated with investing in LUPIN?

Key risks for LUPIN include: Market volatility (Beta: N/A), financial leverage (Debt-to-Equity: 0.32), and operational challenges. The stock has a Fundamental Score of 69.8/100, indicating moderate risk requiring careful monitoring. Sector-specific risks in Pharmaceuticals & Biotechnology include regulatory changes, economic cycles, and competitive pressures. Consider your risk tolerance, investment horizon, and portfolio diversification before investing. Past performance doesn't guarantee future results.

What is LUPIN's operating profit margin and how has it trended?

LUPIN has a 5-year average Operating Profit Margin (OPM) of 14.94%, which is good and shows decent operational efficiency. Operating Profit Margin shows operational efficiency by measuring operating profit as a percentage of revenue. Monitor margin trends to assess management's ability to control costs and improve efficiency. Compare with industry peers to understand relative performance.

How is LUPIN's quarterly performance in terms of sales and profit growth?

LUPIN's recent quarterly performance shows YoY Sales Growth of 11.93% and YoY Profit Growth of 52.13%. This shows decent growth momentum in the business. Sales growth shows market demand while profit growth reveals operational efficiency and margin management.

What is the FII and DII holding pattern in LUPIN?

LUPIN has FII holding of 21.25% and DII holding of 25.55%, totaling 46.80% institutional ownership. High institutional holding indicates professional validation of business quality and growth prospects. Significant FII holding suggests global investor confidence and potential for index inclusion. Monitor quarterly changes in institutional holdings for investment flow trends and sentiment.